Regen BioPharma Inc (152)
Browse by Contract Category
Contracts
-
Convertible Note 5
(Filed With SEC on April 13, 2023)
-
Convertible Note Zander Therapeutics, Inc
(Filed With SEC on April 13, 2023)
-
Convertible Note 4
(Filed With SEC on April 13, 2023)
-
Convertible Note 3
(Filed With SEC on April 13, 2023)
-
Convertible Note 2
(Filed With SEC on April 13, 2023)
-
Convertible Note 1
(Filed With SEC on April 13, 2023)
-
License Agreement Oncology Pharma KCL
(Filed With SEC on April 13, 2023)
-
License Agreement Oncology Pharma Regen
(Filed With SEC on April 13, 2023)
-
Assignment License Agreement Regen Zander
(Filed With SEC on April 13, 2023)
-
License Agreement Regen Zander
(Filed With SEC on April 13, 2023)
-
Hais Agreement
(Filed With SEC on January 19, 2023)
-
Reddy Agreement
(Filed With SEC on January 19, 2023)
-
Dawald Agreement
(Filed With SEC on January 19, 2023)
-
Sublease Agreement
(Filed With SEC on January 14, 2022)
-
BIOTECH ResearchGroup SCOPEOF WORK ( SOW) ORDER
(Filed With SEC on October 19, 2021)
-
Promissory Note
(Filed With SEC on September 24, 2021)
-
Settlement and Release Agreement
(Filed With SEC on September 24, 2021)
-
SETTLEMENT AGREEMENT
(Filed With SEC on September 16, 2021)
-
REGEN BIOPHARMA, INC
(Filed With SEC on April 16, 2021)
-
Regen Agreement
(Filed With SEC on April 8, 2021)
-
KCL Agreement
(Filed With SEC on April 8, 2021)
-
AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND TODD S. CAVEN
(Filed With SEC on March 25, 2021)
-
Form of Convertible Note 50,000
(Filed With SEC on August 29, 2019)
-
Form of Convertible Note $100,000
(Filed With SEC on August 29, 2019)
-
Form of Convertible Note $14,819
(Filed With SEC on August 29, 2019)
-
Form of Convertible Note $20,331
(Filed With SEC on August 29, 2019)
-
Form of Amendment Convertible Note
(Filed With SEC on August 29, 2019)
-
Form of Convertible Note $63,000
(Filed With SEC on February 12, 2019)
-
Form of Convertible Note $63,000
(Filed With SEC on February 12, 2019)
-
Form of Convertible Note $75,000
(Filed With SEC on February 12, 2019)
-
Form of Note Receivable $63,000
(Filed With SEC on February 12, 2019)
-
Form of Convertible Note $50,000
(Filed With SEC on February 12, 2019)
-
Form of Convertible Note $50,000
(Filed With SEC on February 12, 2019)
-
Form of Note Receivable $50,000
(Filed With SEC on February 12, 2019)
-
AGREEMENT BY AND BETWEEN KCL THERAPEUTICS, INC. AND HARRY LANDER
(Filed With SEC on January 25, 2019)
-
LICENSEASSIGNMENT AND CONSENT AGREEMENT
(Filed With SEC on December 27, 2018)
-
STOCKPURCHASEAGREEMENT
(Filed With SEC on November 20, 2018)
-
SUBLEASEAGREEMENT
(Filed With SEC on November 20, 2018)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on October 4, 2018)
-
Form of Convertible Note $114,000
(Filed With SEC on August 6, 2018)
-
Form of Convertible Note $11,500
(Filed With SEC on August 6, 2018)
-
Form of Convertible Note $25,000
(Filed With SEC on May 14, 2018)
-
Form of Convertible Note $30,000
(Filed With SEC on May 14, 2018)
-
Form of Convertible Note $70,000
(Filed With SEC on May 14, 2018)
-
Convertible Note $115,000
(Filed With SEC on May 14, 2018)
-
Unit Purchase Agreement $50,000
(Filed With SEC on May 14, 2018)
-
Agreement with Harry Lander
(Filed With SEC on May 14, 2018)
-
February 7, 2018 Letter Agreement with Zander Therapeutics
(Filed With SEC on May 14, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on February 6, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on February 6, 2018)
-
AGREEMENT BY AND BETWEEN REGENBIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated December 15, 2017
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
GSCAPITAL PARTNERS, LLC COLLATERALIZEDSECURED PROMISSORY NOTE BACKEND NOTE
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
GSCAPITAL PARTNERS, LLC COLLATERALIZEDSECURED PROMISSORY NOTE BACKEND NOTE
(Filed With SEC on January 5, 2018)
-
REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEJUNE 16, 2018
(Filed With SEC on January 5, 2018)
-
LGCAPITAL FUNDING, LLC COLLATERALIZEDSECURED PROMISSORY NOTE BACKEND NOTE
(Filed With SEC on January 5, 2018)
-
REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEAUGUST 23, 2018
(Filed With SEC on January 5, 2018)
-
BACKEND NOTE
(Filed With SEC on January 5, 2018)
-
REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEAUGUST 23, 2018 BACKEND
(Filed With SEC on January 5, 2018)
-
REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUESEPTEMBER 7, 2018
(Filed With SEC on January 5, 2018)
-
REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUE SEPTEMBER 7, 2018 BACKEND NOTE
(Filed With SEC on January 5, 2018)
-
REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUESEPTEMBER 7, 2018
(Filed With SEC on January 5, 2018)
-
REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUESEPTEMBER 7, 2018 BACKEND NOTE
(Filed With SEC on January 5, 2018)
-
REGENBIOPHARMA, INC.
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on January 5, 2018)
-
REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUE DECEMBER 6, 2018
(Filed With SEC on January 5, 2018)
-
REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUE DECEMBER 6, 2018 BACKEND
(Filed With SEC on January 5, 2018)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on August 7, 2017)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on August 7, 2017)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on August 7, 2017)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on August 7, 2017)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on August 7, 2017)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on August 7, 2017)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on May 5, 2017)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on May 5, 2017)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on May 5, 2017)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on May 5, 2017)
-
InvestorRelations Consulting Agreement Between RegenBiopharma Inc. And Synergy Business Consultants LLC
(Filed With SEC on May 5, 2017)
-
LICENSEAGREEMENT
(Filed With SEC on February 9, 2017)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on January 27, 2017)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on January 27, 2017)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on January 27, 2017)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on January 27, 2017)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on January 27, 2017)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on December 21, 2016)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on December 21, 2016)
-
CONVERTIBLE PROMISSORY NOTE
(Filed With SEC on December 21, 2016)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on August 1, 2016)
-
INDEMNIFICATIONAGREEMENT
(Filed With SEC on July 7, 2016)
-
ENGAGEMENTAGREEMENT
(Filed With SEC on June 8, 2016)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on April 29, 2016)
-
RESEARCHCOLLABORATION AGREEMENT
(Filed With SEC on December 17, 2015)
-
UNITPURCHASE AGREEMENT REGENBIOPHARMA, INC.
(Filed With SEC on November 24, 2015)
-
UNITPURCHASE AGREEMENT REGENBIOPHARMA, INC.
(Filed With SEC on November 24, 2015)
-
UNITPURCHASE AGREEMENT REGENBIOPHARMA, INC.
(Filed With SEC on November 24, 2015)
-
UNITPURCHASE AGREEMENT REGENBIOPHARMA, INC.
(Filed With SEC on November 24, 2015)
-
AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND THOMAS ICHIM
(Filed With SEC on November 5, 2015)
-
EMPLOYMENTAGREEMENT BETWEEN REGENBIOPHARMA, INC. AND HarryM. Lander, Ph.D., M.B.A.
(Filed With SEC on October 13, 2015)
-
AMENDMENTTO LICENSE AGREEMENT DATED APRIL 6, 2015
(Filed With SEC on August 26, 2015)
-
AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC.
(Filed With SEC on June 26, 2015)
-
AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND SANTOSH KESARI
(Filed With SEC on June 15, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on May 7, 2015)
-
ConsultingAgreement
(Filed With SEC on March 30, 2015)
-
ConsultingAgreement
(Filed With SEC on March 30, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 25, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 25, 2015)
-
AppendixA DESIGNATEDLEASED SPACE - FLOOR PLAN
(Filed With SEC on March 25, 2015)
-
RESEARCHAGREEMENT
(Filed With SEC on March 25, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 10, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 10, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 10, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 10, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 10, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 10, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 10, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 10, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 10, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on March 10, 2015)
-
PATENTPURCHASE AGREEMENT
(Filed With SEC on March 10, 2015)
-
EMPLOYMENTAGREEMENT BETWEEN REGENBIOPHARMA, INC. AND TODDS. CAVEN
(Filed With SEC on February 13, 2015)
-
EMPLOYMENTAGREEMENT BETWEEN REGENBIOPHARMA, INC. AND DavidR. Koos
(Filed With SEC on February 13, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on February 9, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on February 9, 2015)
-
CONVERTIBLEPROMISSORY NOTE
(Filed With SEC on February 9, 2015)
-
EMPLOYMENTAGREEMENT BETWEEN REGEN BIOPHARMA, INC. AND THOMAS ICHIM
(Filed With SEC on January 22, 2015)
-
EMPLOYMENTAGREEMENT BETWEEN REGEN BIOPHARMA, INC AND CHRISTINE ICHIM
(Filed With SEC on January 22, 2015)
-
AMENDMENTTO SUBLEASE AGREEMENT (AGREEMENT) ENTERED INTO OCTOBER 1, 2014 BY AND BETWEEN ENTEST BIOMEDICAL, INC. ( SUBLESSOR)AND REGEN BIOPHARMA,INC (SUBTENANT)
(Filed With SEC on January 22, 2015)
-
SUBLEASEAGREEMENT
(Filed With SEC on December 18, 2014)
-
ASSIGNMENTOF INVENTION AND PATENT APPLICATION
(Filed With SEC on December 18, 2014)
-
ASSIGNMENTOF INVENTION AND PATENT APPLICATION
(Filed With SEC on December 18, 2014)
-
ASSIGNMENTOF INVENTION AND PATENT APPLICATION
(Filed With SEC on November 25, 2014)
-
ConsultingAgreement
(Filed With SEC on November 25, 2014)
-
PROMISSORYNOTE PAYABLE
(Filed With SEC on August 7, 2014)
-
PROMISSORYNOTE PAYABLE
(Filed With SEC on August 7, 2014)
-
ExclusiveLicense Agreement BetweenOHSU and Regen BioPharma, INC ForInvention Disclosure 0472
(Filed With SEC on October 15, 2013)
-
EMPLOYMENTAGREEMENT BETWEEN BIO-MATRIXSIENTIFIC GROUP, INC. AND J.CHRISTOPHER MIZER
(Filed With SEC on October 15, 2013)
-
EMPLOYMENTAGREEMENT BETWEEN BIO-MATRIXSCIENTIFIC GROUP, INC. AND THOMASICHIM
(Filed With SEC on October 15, 2013)
-
Regen BioPharma Inc. Awholly owned subsidiary of Bio-Matrix Scientific Group Inc.
(Filed With SEC on October 15, 2013)
-
ExclusiveOption to Negotiate an Exclusive License Between OregonHealth & Science University and RegenBioPharma, Inc.
(Filed With SEC on October 15, 2013)
-
REGENBIO PHARMA INC. Awholly owned subsidiary of Bio matrix Scientific Group, Inc.
(Filed With SEC on October 15, 2013)
-
LICENSE AGREEMENT- EXECUTION
(Filed With SEC on October 15, 2013)
-
SERVICEAGREEMENT
(Filed With SEC on October 15, 2013)